Early studies demonstrated cognitive impairments in T cell-deficient mouse models, which were reversed by repopulation with functional T cells [111]
Contraindications include pregnancy, active cancer, uncontrolled endocrine disorders, severe cardiovascular disease, and known peptide hypersensitivity
The jump from 1mg to 4mg, nearly doubling the weight loss percentage, likely represents the addition of meaningful glucagon receptor engagement
Department of Veterans Affairs and Washington University School of Medicine, their impact may extend even further than expected
A 2024 study by KFF revealed that covering GLP-1 drugs for obesity under Medicaid could significantly expand access, benefiting nearly 40% of adults and 26% of children with obesity on Medicaid